Segui questo link per vedere altri tipi di pubblicazioni sul tema: Myelin sheath Diseases Diagnosis.

Libri sul tema "Myelin sheath Diseases Diagnosis"

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-29 libri per l'attività di ricerca sul tema "Myelin sheath Diseases Diagnosis".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi i libri di molte aree scientifiche e compila una bibliografia corretta.

1

J, Valk, e Valk J, a cura di. Magnetic resonance of myelin, myelination, and myelin disorders. 2a ed. Berlin: Springer, 1995.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Knaap, Marjo S. van der., a cura di. Magnetic resonance of myelin, myelination, and myelin disorders. Berlin: Springer-Verlag, 1989.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Marjo S. van der Knaap. Magnetic resonance of myelination and myelin disorders. 3a ed. Berlin: Springer, 2005.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

NATO Advanced Research Workshop on a Multidisciplinary Approach to Myelin Diseases (1986 Rome, Italy). A multidisciplinary approach to myelin diseases. New York: Plenum Press, 1987.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

D, Duncan I., Skoff R. P, Colman D e New York Academy of Sciences., a cura di. Myelination and dysmyelination. New York, N.Y: New York Academy of Sciences, 1990.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Ay-ming, Wang, a cura di. Pediatric cranial MRI: An atlas of normal development. New York: Springer-Verlag, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

J, Vinken P., e Koetsier Johan C, a cura di. Demyelinating diseases. Amsterdam: Elsevier Science Publishers, 1985.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Satellite Symposium on Myelination and Demyelination: Implications for Multiple Sclerosis (1987 Vancouver, B.C.). Myelination and demyelination: Implications for multiple sclerosis. New York: Plenum Press, 1989.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

(Susanne), Pitz S., e SpringerLink (Online service), a cura di. Primary Optic Nerve Sheath Meningioma. Berlin, Heidelberg: Springer-Verlag, 2008.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Valk, Jacob, e Marjo S. van der Knaap. Magnetic Resonance of Myelin, Myelination and Myelin Disorders. Springer London, Limited, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
11

Valk, Jacob, e Marjo S. van der Knaap. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. Springer London, Limited, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
12

Valk, Jaap, e Marjo S. van der Knaap. Magnetic Resonance of Myelination and Myelin Disorders. Springer London, Limited, 2005.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
13

Bisese, John H., e Ay-Ming Wang. Pediatric Cranial MRI: An Atlas of Normal Development. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
14

Bisese, John H., e Ay-Ming Wang. Pediatric Cranial MRI: An Atlas of Normal Development. Springer London, Limited, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
15

Crescenzi, G. Multidisciplinary Approach to Myelin Diseases. Springer London, Limited, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
16

Crescenzi, G. A Multidisciplinary Approach to Myelin Diseases. Springer, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
17

A Multidisciplinary Approach to Myelin Diseases. Springer, 1988.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
18

Salvati, S. Multidisciplinary Approach to Myelin Diseases II. Springer, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
19

S, Salvati, North Atlantic Treaty Organization. Scientific Affairs Division. e NATO Advanced Research Workshop on a Multidisciplinary Approach to Myelin Diseases (2nd : 1993 : Rome, Italy), a cura di. A Multidisciplinary approach to myelin diseases II. New York: Plenum Press, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
20

(Editor), Robert A. Lazzarini, John W. Griffin (Editor), Hans Lassman (Editor), Klaus-Armin Nave (Editor), Robert H. Miller (Editor) e Bruce D. Trapp (Editor), a cura di. Myelin Biology and Disorders. Elsevier Academic Press, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
21

Myelin biology and disorders. San Diego, Calif: Elsevier Academic Press, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
22

Pediatric Cranial MRI: An Atlas of Normal Development. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
23

Publications, ICON Health. Myelin - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
24

Brealey, David, e Nicholas Hirsch. Diagnosis, assessment, and management of Guillain–Barré syndrome. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0246.

Testo completo
Abstract (sommario):
The Guillain–Barré Syndrome describes a spectrum of acute inflammatory polyneuropathies and is the commonest cause of acute flaccid paralysis within the western world. The pathophysiology is complex and poorly understood, but appears to be an immune-mediated destruction of either the myelin sheath and/or the axons, predominantly of motor nerves. The clinical presentation is classically a rapid, ascending, flaccid paralysis, with minimal sensory deficit. This may ascend to involve respiratory or bulbar muscle function. These patients need careful monitoring and, if deteriorating, should be electively intubated and ventilated. Autonomic instability and sensory disturbance, including pain, is common. Treatment of the underlying condition relies upon immunomodulation with either intravenous immunoglobulin or plasma exchange. Supportive care is aimed at maintaining a safe airway, ventilatory support, and managing the complications of autonomic dysfunction and prolonged immobility. Mortality rates range up to 20%, but are significantly better in specialist neuromedical units. Survivors are often left with significant disability.
Gli stili APA, Harvard, Vancouver, ISO e altri
25

Myelination and Demyelination: Implications for Multiple Sclerosis. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
26

Kim, Seung U. Myelination and Demyelination: Implications for Multiple Sclerosis. Springer, 1989.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
27

Kim, Seung U. Myelination and Demyelination: Implications for Multiple Sclerosis. Springer London, Limited, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
28

Kim, Seung U. Myelination and Demyelination: Implications for Multiple Sclerosis. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
29

Compston, Alastair. Multiple sclerosis and other demyelinating diseases. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569381.003.0871.

Testo completo
Abstract (sommario):
The oligodendrocyte–myelin unit subserves saltatory conduction of the nerve impulse in the healthy central nervous system. At one time, many disease processes were thought exclusively to target the structure and function of myelin. Therefore, they were designated ‘demyelinating diseases’. But recent analyses, based mainly on pathological and imaging studies, (re)emphasize that axons are also directly involved in these disorders during both the acute and chronic phases. Another ambiguity is the extent to which these are inflammatory conditions. Here, distinctions should be made between inflammation, as a generic process, and autoimmunity in which rather a specific set of aetiological and mechanistic conditions pertain. And there are differences between disorders that are driven primarily by immune processes and those in which inflammation occurs in response to pre-existing tissue damage.With these provisos, the pathological processes of demyelination and associated axonal dysfunction often account for episodic neurological symptoms and signs referable to white matter tracts of the brain, optic nerves, or spinal cord when these occur in young people. This is the clinical context in which the possibility of ‘demyelinating disease’ is usually considered by physicians and, increasingly, the informed patient. Neurologists will, with appropriate cautions, also be prepared to diagnose demyelinating disease in older patients presenting with progressive symptoms implicating these same pathways even when there is no suggestive past history. Both in its typical and atypical forms multiple sclerosis remains by far the commonest demyelinating disease. But acute disseminated encephalomyelitis, the leucodystrophies, and central pontine myelinolysis also need to be considered in particular circumstances; and multiple sclerosis itself has a differential diagnosis in which the relapsing-remitting course is mimicked by conditions not associated with direct injury to the axon–glial unit. Since our understanding of the cause, pathogenesis and features of demyelinating disease remains incomplete, classification combines aspects of the aetiology, clinical features, pathology, and laboratory components. Whether the designation ‘multiple sclerosis’ encapsulates one or more conditions is now much debated. We anticipate that a major part of future studies in demyelinating disease will be further to resolve this question of disease heterogeneity leading to a new taxonomy based on mechanisms rather than clinical empiricism. But, for now, the variable ages of onset, unpredictable clinical course, protean clinical manifestations, and non-specific laboratory investigations continue to make demyelinating disease one of the more challenging diagnostic areas in clinical neurology.
Gli stili APA, Harvard, Vancouver, ISO e altri
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!

Vai alla bibliografia